Aether Industries Limited (NSEI: AETHER)
Health Care · Pharmaceuticals · IN
Rs1,670.00
-5.49% today · +121.2% 1Y
Aether Industries Limited (NSEI: AETHER) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.30B and employs 817 people.
Over the last twelve months the share price has gained 121.2%, trading between 728.00 and 1.80K.
Tweenvest scores Aether Industries Limited across four factors: quality 66/100, value 32/100, growth 100/100. Its strongest factor is growth.
AETHER price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.30B
- Revenue (TTM)
- $130.09M
- P/E
- 94.11
- EPS
- 17.75
- Dividend yield
- —
- Beta (5Y)
- -0.12
- 52-week high
- Rs1,798.00
- 52-week low
- Rs728.00
- Avg volume (3M)
- —
- Shares outstanding
- 132.71M
- Employees
- 817
- Next earnings
- —
About Aether Industries Limited
Aether Industries Limited operates internationally and within India, specializing in the production and distribution of sophisticated chemical intermediates and specialized chemical compounds. The company's comprehensive product lineup features items such as 4-(2-Methoxyethyl) phenol (4MEP), N-Octyl-D-glucamine (NODG), ortho tolyl benzo nitrile (OTBN), thiophene-2-ethanol (T2E), 1-2-(2Hydroxyethoxy) ethyl piperazine (HEEP), delta-valerolactone (DVL), and bifenthrin alcohol. These chemicals are supplied to a broad array of sectors, including pharmaceuticals, agrochemicals, material science, protective coatings, advanced photography, various additive applications, and the oil and gas industry. Furthermore, Aether Industries extends its expertise through contract research and manufacturing services. Established in 2013, the company's primary operations are situated in Surat, India.
- ISIN
- INE0BWX01014
- Founded
- 2013
- Listed since
- Jun 3, 2022
- Exchange
- National Stock Exchange of India
- Currency
- INR
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Almirall, S.A.BME: ALM | $2.45B | €10.06 | -1.95% |
| Liquidia CorporationNasdaqCM: LQDA | $2.39B | $28.02 | +5.02% |
| Jamjoom Pharmaceuticals Factory CompanySASE: 4015 | $2.36B | SR126.80 | -2.39% |
| BrightGene Bio-Medical Technology Co., Ltd.SHSE: 688166 | $2.32B | CN¥35.81 | +2.31% |
| Bausch Health Companies Inc.NYSE: BHC | $2.30B | $6.04 | -1.79% |
| Tonghua Dongbao Pharmaceutical Co., Ltd.SHSE: 600867 | $2.29B | CN¥7.86 | +1.68% |
| Harmony Biosciences Holdings, Inc.NasdaqGM: HRMY | $2.29B | $39.60 | +0.66% |
| Shandong Buchang Pharmaceuticals Co., Ltd.SHSE: 603858 | $2.27B | CN¥14.64 | +0.83% |
Figures last refreshed Oct 4, 2026.